In vivo Radioiodide Imaging and Treatment of Pancreatic Cancer Xenografts after MUC1 Promoter-Driven Expression of the Human Sodium-Iodide Symporter

Publisher： Karger

E-ISSN： 1424-3911|7|5-6|505-513

ISSN： 1424-3903

Source： Pancreatology, Vol.7, Iss.5-6, 2007-10, pp. : 505-513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Noninvasive 3‐dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 4, 2015-04 ,pp. : 442-453

John Wiley & Sons Inc

Access to resources Recommend Favorite

In Vivo 31P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 41, Iss. 3, 2015-03 ,pp. : 601-609

John Wiley & Sons Inc

Access to resources Recommend Favorite

PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo

By                  

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 995-1002

Spandidos Publications

Access to resources Recommend Favorite

MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology

By Baldus Stephan   Engelmann Katja   Hanisch Franz-Georg  

Critical Reviews in Clinical Laboratory Sciences, Vol. 41, Iss. 2, 2004-03 ,pp. : 189-231

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-1α Enhances Integrin α6β1 Expression and Metastatic Capability of Human Pancreatic Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-08 ,pp. : 167-173

Karger

Access to resources Recommend Favorite